Abstract
Background:
Inflammation and nutrition status have emerged as important factors in impaired wound healing in diabetes. However, the association between inflammation and nutrition-based indicators and diabetic foot ulcer (DFU) has not been reported.
Methods:
This study used a cross-sectional study based on the National Health and Nutrition Examination Survey (NHANES) database and a clinical retrospective study to investigate the association between the inflammation and nutrition-based indicators and DFU. We analyzed data from 31,126 individuals in the NHANES data between 1999 and 2004. Inflammation and nutrition-based indicators included neutrophil–albumin ratio (NAR), monocyte–albumin ratio (MAR), red cell distribution width–albumin ratio (RAR), the hemoglobin, albumin, lymphocyte, and platelet (HALP) score, and prognostic nutritional index (PNI). Binary logistic regression on single and multiple variables and restricted cubic spline were conducted to assess the association and nonlinear relationship between these biomarkers and the prevalence of DFU. Subgroup analyses were performed to evaluate the stability of the associations. Additionally, a retrospective study was conducted to further assess the associations between NAR, MAR, RAR, HALP, PNI, and the prevalence of DFU using binary logistic regression analysis.
Results:
A total of 129 participants with DFUs and 1,515 without DFUs were included in this cross-sectional study. NAR, MAR, RAR, HALP, PNI, and DFU are significantly associated with the prevalence of DFU. After adjusting for all covariates (model 3), the third tertile of NAR (OR = 1.73 [1.09–2.74]), MAR (OR = 1.71 [1.05–2.79]), and RAR (OR = 4.47 [2.57–7.77]) were positively linked with DFU, compared with the first tertile. The third tertile of HALP (OR = 0.50 [0.31–0.80]) and PNI (OR = 0.42 [0.26–0.67]), respectively, were negatively linked with DFU compared with the first tertile. The RCS curves showed a nonlinear relationship between RAR and the prevalence of DFU, with an inflection point at 3.83. In the retrospective study, NAR, MAR, and RAR were positively associated with the prevalence of DFU as follows: NAR: OR = 4.71 (1.99–11.18), MAR: OR = 2.56 (1.23–5.31), and RAR: OR = 6.15 (2.31–16.41). On the other hand, HALP and PNI were negatively linked with the risk of DFU (HALP: OR = 0.93 [0.90–0.97] and PNI: OR = 0.85 [0.78–0.93]).
Conclusion:
High NAR, MAR, and RAR were positively associated with the prevalence of DFU, whereas low HALP and PNI were linked with an increased prevalence of DFU. In addition, RAR performed better in terms of predictive ability.
Introduction
Diabetic foot ulcer (DFU) is the most serious and costly complication of diabetes (). It plays a very important role in the occurrence of vascular disease, neuropathy, and infection of diabetes. In severe cases, amputation is required, which significantly affects the patients’ quality of life. Therefore, early identification of DFU was of great importance.
DFU is typically associated with a persistent inflammatory response (). The levels of inflammatory biomarkers in patients with DFU are significantly increased, including white blood cell count (WBC), C-reactive protein (CRP), procalcitonin, erythrocyte sedimentation rate (ESR), etc. Despite inflammatory biomarkers being closely associated with the diagnosis and prognosis of DFU, they still lack specificity and are influenced by multiple factors. Nutritional status has also been associated with the progression of DFU (). Malnutrition can prolong the inflammatory phase, limit collagen synthesis, and increase the risk of new wound formation (). Albumin level is a common and widely used biomarker used to assess malnutrition (). Previous studies have shown the negative association of DFU with serum albumin levels (). Therefore, it is significant to explore the link between inflammation, nutritional status, and DFU.
Recently, the relationship between inflammation, nutritional status, and DFU has gained great attention from clinicians. Neutrophil–albumin ratio (NAR), which is the ratio of neutrophil count to albumin value, shows potential in assessing the severity of inflammation and predicting the prognosis in infectious diseases (). Monocyte–albumin ratio (MAR), calculated from the ratio of monocytes to albumin, reflects systemic inflammation and nutritional status. Red cell distribution width–albumin ratio (RAR) is a comprehensive and innovative inflammatory biomarker based on both red cell distribution width (RDW) and albumin (). The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel, easily calculated index that combines hemoglobin, albumin, lymphocyte, and platelet counts to provide a comprehensive assessment of both inflammation and nutritional status (). Prognostic nutritional index (PNI) is calculated using albumin levels and peripheral lymphocyte count, and Coşkun et al. found that PNI was associated with an increase in amputation rate in patients with DFU (). Despite their utility as indicators of inflammation and nutritional status, these inflammatory and nutritional biomarkers have not been extensively studied in patients with DFU.
The National Health and Nutrition Examination Survey (NHANES) is a nationally representative cross-sectional study aimed at conducting a comprehensive assessment of the health status and nutritional levels of the US population. In this study, we performed a cross-sectional study based on NHANES database and a clinical retrospective study to evaluate the clinical and predictive value of the inflammation and nutrition-based indicators in patients with DFU. Our aim is to clarify the possible function of NAR, MAR, RAR, HALP, and PNI as prognostic biomarkers for DFU by evaluating their levels and examining their clinical outcomes.
Methods
Data source
Data of this cross-sectional study were derived from the NHANES database. We included data from three NHANES cycles (1999–2000, 2001–2002, and 2003–2004). The NCHS Ethics Review Board approved the NHANES protocol, and all participants provided informed consent. This study strictly adhered to the ethical standards outlined in the 1964 Declaration of Helsinki and its subsequent revisions. The data were extracted for secondary analysis, obviating the need for additional ethical approval.
The clinical retrospective study involving human participants was reviewed and approved by the Ethics Review Board of Shanghai Sixth People’s Hospital. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Study population
In this cohort study, a total of 31,126 individuals from the NHANES database were initially included. The exclusion criteria included participants with missing data on diabetes (n = 28,761), those with missing data on DFU (n = 446), and those with missing data on inflammation and nutrition-based indicators (n = 275). Consequently, our final analysis comprised 1,644 individuals, including 129 with DFUs and 1,515 without DFUs. We presented the selection process in Figure 1.
Figure 1
Variable determination
The baseline characteristics included age, gender (male or female), race/ethnicity, marital status, education level, body mass index (BMI), smoking status, blood pressure, HbAlc, fasting blood glucose (FBG), CRP, WBC, lymphocyte, monocyte, neutrophil, platelet, hemoglobin (Hb), total cholesterol, HDL-cholesterol, albumin, and red cell distribution width (RDW). Diabetes was defined if they had any one of the following symptoms—(1) FBG ≥126 mg/dL, (2) random blood glucose ≥200 mg/dL, (3) HbA1c ≥6.5%, and (4) doctor told you have diabetes/taking insulin now/taking diabetic pills to lower blood sugar—through the diabetes questionnaire. DFU was defined as an ulcer/sore not healed within 4 weeks through the diabetes questionnaire. Smoking was defined as “smoked at least 100 cigarettes in life” or “do you now smoke cigarettes” through the smoking questionnaire. Hypertension status was defined as if they had any one of the following symptoms—(1) systolic blood pressure average ≥140 mmHg, (2) diastolic blood pressure average ≥90 mmHg, and (3) ever told you had high blood pressure/taking prescription for hypertension—through the blood pressure questionnaire. NAR was calculated as neutrophil count/serum albumin. MAR was calculated as monocyte count/serum albumin. RAR was calculated as RDW percentage/serum albumin (g/dL). HALP was calculated as Hb (g/L) × serum albumin (g/L) × lymphocyte count/platelet count. PNI was calculated as serum albumin (g/L) + 5 × lymphocyte count.
Statistical analysis
Data processing and analysis were performed using SPSS 18.0, R version 4.3.3, along with Zstats 1.0 (www.zstats.net). Categorical variables were expressed as frequencies and percentages, and continuous variables were expressed as means and standard deviations. Continuous variables were examined with Student’s t-test, while categorical variables were tested through the chi-square test. Binary logistic regression on single and multiple variables was conducted to examine the relationship between the inflammation and nutrition-based indicators and DFU. We presented three models for multivariate logistic regression: (1) model 1: unadjusted for any other variables, (2) model 2: adjusted for age, gender, and race/ethnicity, and (3) model 3: adjusted for age, gender, race/ethnicity, marital status, education level, smoking, and hypertension. We used restricted cubic spline curve (RCS) and threshold effects analyses to investigate whether there was a nonlinear link in the abovementioned relationships. Subgroup analyses were performed to evaluate the stability of the associations based on age (<65, ≥65), gender, race/ethnicity, marital status, education level, smoking, and hypertension. P-values less than 0.05 were considered statistically significant. The percentage of missing values is less than 5%. To address this issue, missing data for categorical variables were imputed with the highest frequency.
Clinical study
A retrospective study comparing patients with DFU and newly admitted type 2 diabetes patients without DFU was conducted in Shanghai Sixth People’s Hospital from February 2024 to December 2024. This study was approved by our institutional review board. We included patients with type 2 diabetes according to the diagnostic criteria recommended by the American Diabetes Association in 2010 (). We excluded type 1 diabetes, rheumatic disease, cardiovascular disease, renal failure, and malignancy. Patients with chronic wounds due to vasculitis, pyoderma gangrenosum, pressure ulcers, or wound infections not related to DM were excluded.
Clinical characteristics included the patients’ age, gender, BMI, HbAlc, CRP, WBC, lymphocyte, monocyte, neutrophil, platelet, Hb, total cholesterol, HDL-cholesterol, albumin, and RDW. Categorical variables were expressed as frequencies and percentages, and continuous variables were expressed as means and standard deviations. Continuous variables were examined with Student’s t-test, while categorical variables were tested through the chi-square test. A logistic regression analysis was performed to identify the relationship between NAR, MAR, RAR, HALP, PNI, and the prevalence of DFU. Results with P-values less than 0.05 were considered statistically significant.
Results
Participants’ characteristics
We presented the participant’s baseline characteristics in Table 1. A total of 1,644 participants who met the inclusion criteria were included in this study. The mean age was 64.85 years, and 52.25% were men. Among the participants, 129 (7.8%) had DFU. There were no significant differences in age, gender, race/ethnicity, education level, smoking, hypertension, BMI, CRP, lymphocyte, monocyte, platelet, total cholesterol, HDL-cholesterol, and HbAlc. The participants with DFU had higher levels of neutrophil and RDW and lower levels of Hb and albumin. Regarding the inflammation and nutrition-based indicators, participants with DFU had higher NAR, MAR, and RAR and lower HALP and PNI.
Table 1
| Variable | Total (n = 1,644) | DFU (n = 129) | Non-DFU (n = 1,515) | P |
|---|---|---|---|---|
| Age (years) | 65.60 ± 12.14 | 64.79 ± 11.84 | 0.458 | |
| Gender (%) | 0.078 | |||
| Male | 859 | 77 (59.7%) | 782 (51.6%) | |
| Female | 785 | 52 (40.3%) | 733 (48.4%) | |
| Race | 0.623 | |||
| Mexican American | 469 | 40 (31%) | 429 (28.3%) | |
| Other Hispanic | 66 | 6 (4.7%) | 60 (4.0%) | |
| Non-Hispanic White | 681 | 55 (42.6%) | 626 (41.3%) | |
| Non-Hispanic Black | 372 | 26 (20.2%) | 346 (22.8%) | |
| Other race | 56 | 2 (1.6) | 54 (3.6%) | |
| Education level | 0.414 | |||
| Less than high school | 794 | 60 (46.5%) | 734 (48.4%) | |
| High school | 343 | 23 (17.8%) | 320 (21.1%) | |
| Higher than high school | 507 | 46 (35.7%) | 461 (30.4%) | |
| Marital status | 0.046 | |||
| Married/living with partners | 1,020 | 67 (51.9%) | 953 (62.9%) | |
| Widowed/divorced/separated | 530 | 52 (40.3%) | 478 (31.6%) | |
| Never married | 94 | 10 (7.8%) | 84 (5.5%) | |
| Smoking | 0.618 | |||
| Yes | 883 | 72 (55.8%) | 811 (53.5%) | |
| No | 761 | 57 (44.2%) | 704 (46.5%) | |
| hypertension | 0.448 | |||
| Yes | 1,189 | 97 (75.2%) | 1,092 (72.1%) | |
| No | 455 | 32 (24.8%) | 423 (27.9%) | |
| BMI (kg/m2) | 31.70 ± 7.78 | 30.63 ± 6.49 | 0.078 | |
| CRP (mg/dL) | 0.85 ± 1.22 | 0.70 ± 1.50 | 0.285 | |
| WBC (109) | 7.78 ± 2.41 | 7.44 ± 2.14 | 0.097 | |
| Lymphocyte (109) | 2.03 ± 0.86 | 2.17 ± 0.93 | 0.084 | |
| Monocyte (109) | 0.61 ± 0.21 | 0.58 ± 0.19 | 0.139 | |
| Neutrophil (109) | 4.84 ± 1.96 | 4.44 ± 1.62 | 0.007 | |
| Hb (g/dL) | 13.68 ± 1.63 | 14.15 ± 1.58 | 0.001 | |
| Platelet (109) | 259.34 ± 75.26 | 257.50 ± 73.04 | 0.784 | |
| Total cholesterol (mg/dL) | 196.57 ± 45.59 | 203.51 ± 42.51 | 0.077 | |
| HDL-cholesterol (mg/dL) | 47.43 ± 16.73 | 48.17 ± 14.36 | 0.578 | |
| Albumin (g/dL) | 4.03 ± 0.35 | 4.18 ± 0.35 | <0.001 | |
| RDW (%) | 13.44 ± 1.31 | 13.07 ± 1.31 | 0.002 | |
| HbA1c (%) | 7.23 ± 2.31 | 7.08 ± 1.83 | 0.437 | |
| NAR | 1.20 ± 0.49 | 1.07 ± .042 | 0.001 | |
| MAR | 0.15 ± 0.05 | 0.14 ± 0.05 | 0.016 | |
| RAR | 3.37 ± 0.55 | 3.16 ± 0.50 | <0.001 | |
| HALP | 46.03 ± 23.31 | 53.32 ± 30.71 | 0.008 | |
| PNI | 50.46 ± 6.03 | 52.66 ± 5.84 | <0.001 |
Baseline characteristics of the study population.
HBP, high blood pressure; RDW, red cell distribution width; NAR, neutrophil-albumin ratio; MAR, monocyte-albumin ratio; RAR, red cell distribution width-albumin ratio; HALP, hemoglobin, albumin, lymphocyte, and platelet; PNI, prognostic nutritional index.
Association between the inflammation and nutrition-based indicators and DFU
We presented the relationship between the inflammation and nutrition-based indicators and DFU in Table 2. When analyzed in continuous form, a significant correlation between NAR, MAR, RAR, HALP, PNI, and DFU was observed in the unadjusted model l, adjusted model 2, and adjusted model 3.
Table 2
| Variable | Model 1 | P | Model 2 | P | Model 3 | P |
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| NAR | 1.815 (1.277, 2.581) | 0.001 | 1.832 (1.284, 2.615) | 0.001 | 1.819 (1.271, 2.604) | 0.001 |
| NAR tertiles | ||||||
| Tertiles 1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
| Tertiles 2 | 1.17 (0.73,1.89) | 0.518 | 1.16 (0.72, 1.88) | 0.543 | 1.17 (0.72, 1.90) | 0.532 |
| Tertiles 3 | 1.76 (1.12,2.75) | 0.013 | 1.80 (1.14, 2.83) | 0.012 | 1.73 (1.09, 2.74) | 0.020 |
| P-trend | 0.009 | 0.008 | 0.014 | |||
| MAR | 1.449 (1.067, 1.969) | 0.018 | 1.461 (1.072, 1.991) | 0.016 | 1.434 (1.051, 1.957) | 0.023 |
| MAR tertiles | ||||||
| Tertiles 1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
| Tertiles 2 | 1.72 (1.07, 2.78) | 0.025 | 1.73 (1.07, 2.79) | 0.026 | 1.76 (1.09, 2.86) | 0.022 |
| Tertiles 3 | 1.76 (1.09, 2.84) | 0.021 | 1.75 (1.08, 2.84) | 0.024 | 1.71 (1.05, 2.79) | 0.033 |
| P-trend | 0.030 | 0.034 | 0.048 | |||
| RAR | 1.828 (1.393, 2.398) | <0.001 | 1.979 (1.497, 2.616) | <0.001 | 1.939 (1.461, 2.572) | <0.001 |
| RAR tertiles | ||||||
| Tertiles 1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
| Tertiles 2 | 2.38 (1.37, 4.14) | 0.002 | 2.62 (1.50, 4.57) | <.001 | 2.54 (1.45, 4.45) | 0.001 |
| Tertiles 3 | 3.78 (2.23, 6.38) | <.001 | 4.71 (2.72, 8.16) | <.001 | 4.47 (2.57, 7.77) | <.001 |
| P-trend | <0.001 | <0.001 | <0.001 | |||
| HALP | 0.987 (0.978, 0.996) | 0.004 | 0.985 (0.976, 0.994) | 0.002 | 0.986 (0.977, 0.995) | 0.003 |
| HALP tertiles | ||||||
| Tertiles 1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
| Tertiles 2 | 0.66 (0.43, 1.00) | 0.053 | 0.64 (0.42, 0.98) | 0.040 | 0.66 (0.43, 1.02) | 0.063 |
| Tertiles 3 | 0.53 (0.34, 0.84) | 0.006 | 0.49 (0.31, 0.78) | 0.002 | 0.50 (0.31, 0.80) | 0.003 |
| P-trend | 0.007 | 0.003 | 0.004 | |||
| PNI | 0.932 (0.901, 0.963) | <0.001 | 0.930 (0.899, 0.962) | <0.001 | 0.935 (0.903, 0.967) | <0.001 |
| PNI tertiles | ||||||
| Tertiles 1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | |||
| Tertiles 2 | 0.56 (0.36, 0.85) | 0.006 | 0.54 (0.35, 0.83) | 0.005 | 0.54 (0.35, 0.84) | 0.005 |
| Tertiles 3 | 0.42 (0.26, 0.66) | <0.001 | 0.41 (0.26, 0.65) | <0.001 | 0.42 (0.26, 0.67) | <0.001 |
| P-trend | <0.001 | <0.001 | <0.001 | |||
Association of NAR, MAR, RAR, HALP, and PNI with the prevalence of DFU.
Model 1, unadjusted model; Model 2, adjusted for sex, age, and race; Model 3, adjusted for sex, age, race, educational level, marital status, smoking, and hypertension.
We divided NAR, MAR, RAR, HALP, and PNI into tertiles. In model 1, the risk of DFU among those in the third tertile compared with those in the first tertile was increased by 76% (OR = 1.76 [1.12–2.75]) for NAR, 76% (OR = 1.76 [1.09–2.84]) for MAR, and 278% (OR = 3.78 [2.23–6.38]) for RAR. The risk of DFU among those in the third tertile compared with those in the first tertile was decreased by 47% (OR = 0.53 [0.34–0.84]) for HALP and 58% (OR = 0.42 [0.26–0.66]) for PNI. After adjusting for all covariates (model 3), the third tertile of NAR (OR = 1.73 [1.09–2.74]), MAR (OR = 1.71 [1.05–2.79]), and RAR (OR = 4.47 [2.57–7.77]) were positively linked with DFU compared with the first tertile. The third tertile of HALP (OR = 0.50 [0.31–0.80]) and PNI (OR = 0.42 [0.26–0.67]), respectively, were negatively linked with DFU compared with the first tertile.
The RCS analyses showed that the relationship between NAR, MAR, HALP, PNI, and DFU was linear (P for nonlinearity >0.05), whereas the relationship between RAR and DFU was nonlinear (P for nonlinearity <0.05) (Figure 2). The threshold effects analyses indicated that the inflection point of RAR was 3.83 (Table 3). When RAR was less than 3.83, the risk of DFU escalated with an increasing ratio. Conversely, when the ratio exceeded 3.83, the association between RAR and DFU was not statistically significant.
Figure 2
Table 3
| Outcome | Effect | P |
|---|---|---|
| Model 1: Fitting model by standard linear regression | 1.96 (1.47–2.63) | <0.001 |
| Model 2: Fitting model by two-piecewise linear regression | ||
| Inflection point | 3.83 | |
| <3.83 | 5.55 (2.87–10.75) | <0.001 |
| ≥3.83 | 0.89 (0.36–2.20) | 0.803 |
| P for likelihood test | <0.001 | |
Threshold effect analysis of RAR on DFU.
RAR, red cell distribution width–albumin ratio.
Subgroup analysis
Subgroup analyses were performed to determine the potential effect modifications on the relationship between NAR, MAR, RAR, HALP, and PNI and the prevalence of DFU. The relationships between RAR, HALP, PNI, and DFU were not influenced by age, gender, race, education level, marital status, smoking, and hypertension. However, a significant interaction effect was observed in the age subgroup for NAR (P-value for interaction = 0.022) and in the gender subgroup for MAR (P-value for interaction = 0.004) (Figure 3).
Figure 3
Clinical study
In this retrospective study, 36 patients with DFU and 49 diabetic patients without DFU were included. There was no significant difference in age, BMI, lymphocyte, monocyte, RDW, and total cholesterol. Compared with the non-DFU group, patients with DFU had higher levels of CRP, WBC, neutrophil, Hb, platelet, and RDW and lower levels of HDL-cholesterol and albumin. Regarding the inflammation and nutrition-based indicators, patients with DFU had higher NAR, MAR, and RAR and lower HALP and PNI (Table 4).
Table 4
| Variable | DFU (n = 36) | Non-DFU (n = 48) | P |
|---|---|---|---|
| Age (years) | 66.86 ± 10.02 | 70.85 ± 8.71 | 0.055 |
| Gender (%) | 0.006 | ||
| Male | 28 (77.8%) | 23 (47.9%) | |
| Female | 8 (22.2%) | 25 (52.1%) | |
| BMI (kg/m2) | 24.36 ± 3.39 | 25.18 ± 3.46 | 0.280 |
| CRP (mg/dL) | 40.91 ± 64.02 | 2.73 ± 5.77 | <0.001 |
| WBC (109) | 8.82 ± 4.46 | 6.36 ± 2.66 | 0.002 |
| Lymphocyte (109) | 1.50 ± 0.61 | 1.63 ± 0.60 | 0.353 |
| Monocyte (109) | 0.56 ± 0.26 | 0.50 ± 0.17 | 0.211 |
| Neutrophil (109) | 6.59 ± 4.49 | 4.02 ± 2.20 | 0.001 |
| Hb (g/dL) | 11.47 ± 2.18 | 13.21 ± 1.64 | <0.001 |
| Platelet (109) | 265.50 ± 69.54 | 198.13 ± 62.68 | <0.001 |
| Total cholesterol (mg/dL) | 152.83 ± 56.50 | 148.55 ± 50.17 | 0.715 |
| HDL-cholesterol (mg/dL) | 35.51 ± 10.22 | 43.90 ± 10.88 | 0.001 |
| Albumin (g/dL) | 3.36 ± 0.52 | 3.91 ± 0.39 | <0.001 |
| RDW (%) | 13.69 ± 1.91 | 13.22 ± 1.31 | 0.188 |
| HbA1c (%) | 8.67 ± 2.13 | 7.15 ± 1.47 | 0.001 |
| NAR | 2.08 ± 1.73 | 1.03 ± 0.56 | <0.001 |
| MAR | 0.18 ± 0.10 | 0.13 ± 0.04 | 0.005 |
| RAR | 4.18 ± 0.91 | 3.41 ± 0.49 | <0.001 |
| HALP | 24.71 ± 18.32 | 45.22 ± 19.31 | <0.001 |
| PNI | 41.11 ± 6.85 | 47.28 ± 5.71 | <0.001 |
Clinical characteristics of the retrospective study.
RDW, red cell distribution width; NAR, neutrophil–albumin ratio; MAR, monocyte–albumin ratio; RAR, red cell distribution width–albumin ratio; HALP, hemoglobin, albumin, lymphocyte, and platelet; PNI, prognostic nutritional index.
The associations of NAR, MAR, RAR, HALP, and PNI with the dependent variable DFU were examined in the logistic regression analyses (Table 5). The results showed that NAR, MAR, and RAR were positively associated with the prevalence of DFU as follows: NAR: OR = 4.71 (1.99–11.18), MAR: OR = 2.56 (1.23–5.31), and RAR: OR = 6.15 (2.31–16.41). On the other hand, HALP and PNI were negatively linked with the risk of DFU (HALP: OR = 0.93 [0.90–0.97] and PNI: OR = 0.85 [0.78–0.93]).
Table 5
| Variables | β | S.e. | Z | P | OR (95% CI) |
|---|---|---|---|---|---|
| NAR | 1.55 | 0.44 | 3.52 | <0.001 | 4.71 (1.99–11.18) |
| MAR | 0.94 | 0.37 | 2.51 | 0.012 | 2.56 (1.23–5.31) |
| RAR | 1.82 | 0.50 | 3.63 | <0.001 | 6.15 (2.31–16.41) |
| HALP | -0.07 | 0.02 | -3.86 | <0.001 | 0.93 (0.90–0.97) |
| PNI | -0.17 | 0.04 | -3.68 | <0.001 | 0.85 (0.78–0.93) |
Logistic regression predicting the likelihood of DFU on NAR, MAR, RAR, HALP, and PNI.
NAR, neutrophil–albumin ratio; MAR, monocyte–albumin ratio; RAR, red cell distribution width–albumin ratio; HALP, hemoglobin, albumin, lymphocyte, and platelet; PNI, prognostic nutritional index.
Discussion
In our study, we discussed the relationship between various inflammation and nutrition-based indicators and DFU using both NHANES data and a retrospective analysis. The cross-sectional study suggested that certain biomarkers such as NAR, MAR, RAR, HALP, and PNI were associated with the prevalence of DUF. Higher levels of NAR, MAR, and RAR were associated with an increased prevalence of DFU, while lower levels of HALP and PNI were linked with an increased prevalence of DFU. The results of RCS showed linear associations between NAR, MAR, HALP, PNI, and DFU, whereas the relationship between RAR and DFU was nonlinear. We further performed a retrospective study based on the clinical cases to clarify the relationship between NAR, MAR, RAR, HALP, and PNI with the prevalence of DFU. Similar to the results of the cross-sectional study, we found that NAR, MAR, RAR, HALP, and PNI were significantly associated with the prevalence of DFU. Overall, our findings underscored the importance of monitoring and managing inflammation and nutritional status in participants with DFU.
Inflammation and nutrition status have emerged as important factors in impaired wound healing in diabetes. Recent studies have emphasized the importance of chronic inflammation, which is maintaining a pro-inflammatory environment dominated by cytokines, such as TNF-α, IL-1β, and IL-6, and impairing angiogenesis and delaying wound repair (). Malnutrition can prolong the inflammatory phase, limit collagen synthesis, and increase the risk of new wound formation (). In the previous cross-sectional studies from the NHANES database, the inflammation and nutrition biomarkers such as SIRI and anemia have been proven to have a positive correlation with the prevalence of DFU (, ). However, it is insufficient to evaluate the occurrence of DFU only based on inflammation or malnutrition. A study has proved that inflammation negatively impacts nutritional status through multiple pathways, such as TNF-α and CRP (). On the other hand, nutritional status like low albumin and vitamin D deficiency can trigger exaggerated immune responses, prolonging inflammation (). There is an urgent need for a new and comprehensive indicator to effectively evaluate the correlation between inflammation, nutritional status, and DFU.
NAR is the ratio of neutrophil to albumin, and MAR is the ratio of monocytes to albumin. Both are novel inflammatory biomarkers, mainly reflecting the balance between systemic inflammation and nutritional status. The chronic hyperglycemic state of diabetes has been implicated in impaired neutrophil functions, which prolong the inflammatory phase and disrupt the delicate balance required for effective wound healing (). In DFUs, an elevated neutrophil count is generally observed. High neutrophil production causes increased NETosis and leads to subsequent delays in wound healing (). Monocytes are the major source of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) as well as anti-inflammatory cytokines (IL-4 and IL-10), which play a key role in the development and maintenance of the inflammatory response (). The correct timing, intensity, and balance changes in the expression of pro-inflammatory and anti-inflammatory cytokines in monocytes result in the pathologic regulation of the inflammatory response. DFU is characterized by low-grade systemic inflammation, which may cause altered recruitment and an increased presence of myeloid cells (monocytes and neutrophils) at the wound site (). In addition, protein deficiency has been demonstrated to contribute to poor healing rates with reduced collagen formation and wound dehiscence (). Evaluating both serum inflammation levels and nutrition can provide valuable insights into early steps to develop a treatment strategy and predict the prognosis of DFU patients. In our cross-sectional study, compared with the first tertile, DFU prevalence increased by 73% and 71% in the third tertile of NAR and MAR, respectively. In the retrospective study, NAR (OR = 4.71 [1.99–11.18]) and MAR (OR = 2.56 [1.23–5.31]) were positively linked with the prevalence of DFU. Both of the two biomarkers show a high correlation with the prevalence of DFU.
RAR is defined as the ratio of RDW to albumin. Elevated RDW levels suggest an imbalance in red blood cells stemming from impaired erythropoiesis and abnormal red blood cell survival (). Previous studies have shown that RAR is a new combined parameter that can predict mortality in patients with burn surgery (), diabetic retinopathy (), and diabetic ketoacidosis (). Chronic wounds are normally associated with a persistent inflammatory response, which contributes to an increased RDW through myelosuppression. This imbalance can promote erythrocyte apoptosis and erythropoietin resistance and reduce erythropoietin production and the bioavailability of iron (). In addition, hyperglycemia induces oxidative stress, leading to red blood cell damage and an increase in the heterogeneity of red blood cell volume distribution. In this regard, high RDW and low albumin may be a marker of poor general health and healing abilities of patients with diabetic foot ulcers (). In the cross-sectional study, compared with the first tertile, the prevalence of DFU increased by 374% in the third tertile of RAR. In the retrospective study, the odds ratios of RAR for the risk of DFU was 6.15 (95% CI: 2.31–16.41). These results indicated a high correlation between RAR and the prevalence of DFU. In addition, a nonlinear correlation between RAR and the prevalence of DFU was observed by RCS analysis. The RCS curves showed an L-shape relationship between RAR and the prevalence of DFU, with an inflection point at 3.83. The RAR was positively correlated with the prevalence of DFU, when RAR was less than 3.83. In the clinical setting, these findings underscore the value of RAR as an indicator for risk of DFU.
HALP, an immune nutritional indicator, was initially introduced by Chen et al. as a scoring system to predict the prognosis of gastric cancer (). It has been used to assess the relationship with the prevalence of non-neoplastic disease. Ding et al. found that a lower HALP (≤42.9) score was an independent risk factor for diabetic retinopathy (). Zhao et al. reported that the HALP score was negatively correlated with both all-cause and CVD mortality risk in patients with diabetes or pre-diabetes (). Each component of the HALP score—hemoglobin, albumin, lymphocytes, and platelets—plays a key role in the development and prognosis of DFU. Low levels of hemoglobin are thought to aggravate lower limb ischemia owing to reduced blood oxygen (). It has also been reported to cause thrombosis by inducing a hyperkinetic circulatory state and upregulating the endothelial adhesion molecule genes (). Albumin is essential for collagen formation, angiogenesis, and cellular regeneration, all of which are crucial for wound healing (). Albumin has antioxidant and anti-inflammatory properties, and low levels can trigger a chronic inflammatory response (). Lymphocytes are important regulators of inflammation and wound healing progression. Lymphocytes obtained from DFU patients showed an accumulation of ROS, membrane damage, increased protein carbonyls, and altered SOD and catalase activity (). An activated platelet not only releases inflammatory mediators but also promotes thrombosis by adhering to damaged vascular endothelium, resulting in atherosclerosis and local ischemia (). PNI provided the nutritional and inflammation status of patients based on albumin levels and lymphocytes. Sun et al. found that patients with DFU-induced sepsis had a significantly lower PNI than those without sepsis (). Yılmaz et al. reported that PNI had a significant predictive value for 30-day mortality after below-knee amputation in DFU patients (). In our cross-sectional study, the prevalence of DFU decreased by 47% and 58% in the third tertile of HALP and PNI, respectively. In the retrospective study, HALP (HALP: OR = 0.93 [0.90–0.97]) and PNI (OR = 0.85 [0.78–0.93]) were negatively linked with the risk of DFU.
To our knowledge, this is the first study to demonstrate a relationship between NAR, MAR, RAR, HALP, and PNI and the prevalence of DFU. As comprehensive biomarkers, NAR, MAR, RAR, HALP, and PNI reflect both systemic inflammatory responses and nutritional status, two factors that are critically involved in the progression of DFU. We demonstrated that these inflammation and nutrition-based indicators were significantly associated with the prevalence of DFU; especially RAR performed better predictive ability. All of these biomarkers rely on direct laboratory tests and have the advantages of being easy to use and inexpensive, which make them potentially applicable in various clinical settings.
This study combined a cross-sectional study and an observational, retrospective study, which enrolled DFU cases from individuals (NHANES) and hospitalized patients, offering a comprehensive view of the potential relationships between the inflammation and nutrition-based indicators and DFU. This study has several advantages: (1) the cross-sectional study utilizes the largest population-level data based on the NHANES database, (2) multiple statistical methods, including multivariate adjustment, RCS, and threshold effects analyses and subgroup analyses were employed to increase the credibility and authenticity of our conclusions, and (3) an observational, retrospective study was conducted to strengthen the validity of our findings.
Despite the strengths of this study, several limitations should be considered. First, the cross-sectional design of NHANES limits our ability to capture longitudinal changes or respond to intervention measures. Second, some data in the cross-sectional study was obtained through family interviews and surveys, which raise the possibility of self-report bias or recall bias. Third, the cross-sectional study used a representative sample of the U.S. population, and our retrospective study was primarily based on Chinese population. It is very important to conduct further researches involving a broader, more diverse population. In addition, the sample size included in this retrospective study was too small, and further large-scale studies are necessary. Finally, despite adjusting for known factors such as age, gender, race, education level, marital status, smoking, and hypertension, potential confounding factors may still exist. More well-designed and large-sample studies are needed in the future.
Conclusion
This study used a cross-sectional study based on NHANES database and a clinical retrospective study to investigate the association between the inflammation and nutrition-based indicators and DFU. It concluded that inflammation and nutrition-based indicators are significantly associated with the prevalence of DFU. High NAR, MAR, and RAR, respectively, were positively associated with the prevalence of DFU, whereas low HALP and PNI were linked with an increased prevalence of DFU. In addition, RAR performed better predictive ability. Continuous and dynamic monitoring of inflammation and nutritional status may contribute to the early diagnosis and treatment of DFU.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.
Ethics statement
The studies involving humans were approved by The NCHS Ethics Review Board and the Ethic Review Board of Shanghai Sixth People’s Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
HC: Methodology, Writing – review & editing, Investigation. YZ: Investigation, Writing – review & editing, Methodology. JD: Writing – review & editing, Methodology, Writing – original draft, Conceptualization.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. Sponsorship for this study and article processing charges was supported by CAAC Shanghai Hospital-Level Project (2025mhyk003).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
ChenHMeiSZhouYDaiJ. Systematic review and meta-analysis of the diagnostic accuracy of inflammatory markers for infected diabetic foot ulcer. J Tissue Viability. (2024) 33:598–607. doi: 10.1016/j.jtv.2024.09.007
2
MirzaREFangMMWeinheimer-HausEMEnnisWJKohTJ. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes. (2014) 63:1103–14. doi: 10.2337/db13-0927
3
RanQXuWZhaoXSunHLiuLLuoY. Risk factors for malnutrition in patients with diabetic foot ulcer and its association with prolonged length of hospitalization. Nutr Diabetes. (2024) 14:26. doi: 10.1038/s41387-024-00290-6
4
SkórkaMBazalińskiDWięchPKłękSKoziełDSierżantowiczR. Nutritional status in a group of patients with wounds due to diabetic foot disease and chronic venous insufficiency. J Clin Med. (2024) 14:43. doi: 10.3390/jcm14010043
5
SolakogluGANuhoğluÇAlBAdakNAArslanB. Prognostic factors influencing survival in nonagenarian patients admitted to the emergency department: a retrospective study. BMC Geriatr. (2025) 25:391. doi: 10.1186/s12877-025-06047-9
6
LiMZTangFLiuYFLaoJHYangYCaoJet al. Risk factors and a predictive model of diabetic foot in hospitalized patients with type 2 diabetes. World J Diabetes. (2025) 16:95644. doi: 10.4239/wjd.v16.i3.95644
7
LiYWangHLiuZDengZHuangKLiGet al. Neutrophil-albumin ratio serves as a superior prognostic biomarker for traumatic brain injury. Sci Rep. (2024) 14:27563. doi: 10.1038/s41598-024-78362-x
8
HuangDWangKDengTYangTCaoJ. Association Between red Cell Distribution Width/Albumin Ratio and Diabetic Lower Extremity Ulcers (DLEU) among US Outpatients in the NHANES: A Retrospective Cross-Sectional Study. Int J Low Extrem Wounds. (2024), 15347346241273156. doi: 10.1177/15347346241273156
9
HeYMaZChenXWangJChenXDengZet al. Association between hemoglobin, albumin, lymphocyte, and platelet score and all-cause and cardiovascular mortality among population with diabetes: Evidence from the NHANES 2003-2016. Diabetes Res Clin Pract. (2025) 224:112212. doi: 10.1016/j.diabres.2025.112212
10
CoşkunBAyhanMUlusoyS. Relationship between prognostic nutritional index and amputation in patients with diabetic foot ulcer. Diagnost (Basel). (2024) 14:738. doi: 10.3390/diagnostics14070738
11
American-Diabetes-Association. Standards of medical care in diabetes–2010. Diabetes Care. (2010) 33 Suppl 1:S11–61. doi: 10.2337/dc10-S011
12
DawiJTumanyanKTomasKMisakyanYGargaloyanAGonzalezEet al. Diabetic foot ulcers: pathophysiology, immune dysregulation, and emerging therapeutic strategies. Biomedicines. (2025) 13:1076. doi: 10.3390/biomedicines13051076
13
CaoJWangJZhangSGaoG. Association between anemia and diabetic lower extremity ulcers among US outpatients in the National Health and Nutrition Examination Survey: a retrospective cross-sectional study. Front Endocrinol (Lausanne). (2024) 15:1387218. doi: 10.3389/fendo.2024.1387218
14
HuYXiongFZhaoLWanFHuXShenYet al. Association between systemic inflammatory response index and diabetic foot ulcer in the US population with diabetes in the NHANES: A retrospective cross-sectional study. Int J Low Extrem Wounds. (2025) 24:611–20. doi: 10.1177/15347346251324478
15
LiuYYangYLiYDingWYangX. Association between nutritional and inflammatory status and mortality outcomes in patients with osteoporosis and osteopenia. J Nutr Biochem. (2025) 143:109936. doi: 10.1016/j.jnutbio.2025.109936
16
AoTKikutaJIshiiM. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. (2021) 11:1624. doi: 10.3390/biom11111624
17
XuFZhangCGravesDT. Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. BioMed Res Int. (2013) 2013:754802. doi: 10.1155/2013/754802
18
RASNambiNRadhakrishnanLPrasadMKRamkumarKM. Neutrophil migration is a crucial factor in wound healing and the pathogenesis of diabetic foot ulcers: insights into pharmacological interventions. Curr Vasc Pharmacol. (2024) 23:98–112. doi: 10.2174/0115701611308960241014155413
19
UccioliLSinistroAAlmerighiCCiapriniCCavazzaAGiuratoLet al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care. (2010) 33:350–5. doi: 10.2337/dc09-1141
20
RaghavanJVDoraiVKSagarSKSivaramanARKSJhunjhunwalaS. Immunomodulatory bandage for accelerated healing of diabetic wounds. ACS Bio Med Chem Au. (2022) 2:409–18. doi: 10.1021/acsbiomedchemau.1c00063
21
RussellL. The importance of patients’ nutritional status in wound healing. Br J Nurs. (2001) 10:S42, s44–49. doi: 10.12968/bjon.2001.10.Sup1.5336
22
SeoYJYuJParkJYLeeNLeeJParkJHet al. Red cell distribution width/albumin ratio and 90-day mortality after burn surgery. Burns Trauma. (2022) 10:tkab050. doi: 10.1093/burnst/tkab050
23
ZhaoFLiuMKongL. Association between red blood cell distribution width-to-albumin ratio and diabetic retinopathy. J Clin Lab Anal. (2022) 36:e24351. doi: 10.1002/jcla.24351
24
ZhouDWangJLiX. The red blood cell distribution width-albumin ratio was a potential prognostic biomarker for diabetic ketoacidosis. Int J Gen Med. (2021) 14:5375–80. doi: 10.2147/IJGM.S327733
25
HongJHuXLiuWQianXJiangFXuZet al. Impact of red cell distribution width and red cell distribution width/albumin ratio on all-cause mortality in patients with type 2 diabetes and foot ulcers: a retrospective cohort study. Cardiovasc Diabetol. (2022) 21:91. doi: 10.1186/s12933-022-01534-4
26
YoonYKParkJHChoHHShimDWLeeWHanSHet al. Red blood cell distribution width is an independent predictor of mortality following amputation for diabetic foot. Sci Rep. (2025) 15:4441. doi: 10.1038/s41598-025-85684-x
27
ChenXLXueLWangWChenHNZhangWHLiuKet al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. (2015) 6:41370–82. doi: 10.18632/oncotarget.5629
28
DingRZengYWeiZHeZJiangZYuJet al. The L-shape relationship between hemoglobin, albumin, lymphocyte, platelet score and the risk of diabetic retinopathy in the US population. Front Endocrinol (Lausanne). (2024) 15:1356929. doi: 10.3389/fendo.2024.1356929
29
ZhaoPZhangZLiMHaoJWangY. Association between Hemoglobin-albumin-lymphocyte-platelet score and all-cause or cardiovascular mortality in patients with diabetes or prediabetes: mediated effects of renal function. BMC Cardiovasc Disord. (2025) 25:331. doi: 10.1186/s12872-025-04791-9
30
YammineKHayekFAssiC. Is there an association between anemia and diabetic foot ulcers? A systematic review and meta-analysis. Wound Repair Regener. (2021) 29:432–42. doi: 10.1111/wrr.12902
31
ChuanFZhangMYaoYTianWHeXZhouB. Anemia in patients with diabetic foot ulcer: prevalence, clinical characteristics, and outcome. Int J Low Extrem Wounds. (2016) 15:220–6. doi: 10.1177/1534734616660224
32
ChahrourMAKharroubiHAl TannirAHAssiSHabibJRHoballahJJ. Hypoalbuminemia is associated with mortality in patients undergoing lower extremity amputation. Ann Vasc Surg. (2021) 77:138–45. doi: 10.1016/j.avsg.2021.05.047
33
RastogiAGuptaRGhoshJJudeEB. Renal foot in diabetes: implications for wound healing and solutions. Adv Wound Care (New Rochelle). (2025). doi: 10.1089/wound.2025.0074
34
AryaAKPokhariaDTripathiK. Relationship between oxidative stress and apoptotic markers in lymphocytes of diabetic patients with chronic non healing wound. Diabetes Res Clin Pract. (2011) 94:377–84. doi: 10.1016/j.diabres.2011.08.004
35
LiZGuoHFuZLiDZhangYZhuRet al. Association between hemoglobin, albumin, lymphocyte, and platelet score and diabetic foot ulcer: A cross-sectional study. Int J Low Extrem Wounds. (2025), 15347346251355578. doi: 10.1177/15347346251355578
36
SunBChenYManYFuYLinJChenZ. Clinical value of neutrophil-to-lymphocyte ratio and prognostic nutritional index on prediction of occurrence and development of diabetic foot-induced sepsis. Front Public Health. (2023) 11:1181880. doi: 10.3389/fpubh.2023.1181880
37
YilmazSKurtMDülgeroğluTCÜzümcügilAO. Predictive value of systemic immune inflammation index (SII) and prognostic nutritional index (PNI) on mortality after below-knee amputation. Med (Baltimore). (2023) 102:e35703. doi: 10.1097/MD.0000000000035703
Summary
Keywords
inflammation, nutrition, biomarker, DFU, NHANES, retrospective study
Citation
Chen H, Zhou Y and Dai J (2025) Association of inflammation and nutrition-based indicators and diabetic foot ulcers: a cross-sectional study and a retrospective study. Front. Endocrinol. 16:1654831. doi: 10.3389/fendo.2025.1654831
Received
01 July 2025
Accepted
25 August 2025
Published
16 September 2025
Volume
16 - 2025
Edited by
Hidetaka Hamasaki, Japanese Academy of Health and Practice, Japan
Reviewed by
Jani Almeida, University of Coimbra, Portugal
Sabyasachi Mohanty, University of Nebraska-Lincoln, United States
Harpreet Kaur, Panjab University, India
Updates
Copyright
© 2025 Chen, Zhou and Dai.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yu Zhou, 18321813353@163.com; Jiezhi Dai, daijiezhi@aliyun.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.